COO  Cooper Companies Inc. (The)

Exchange

NYSE

Sector

Health Care

Industry

Ophthalmic Goods

Market Cap.

7.86B

Vuru Grade

48.79/100

Current Price

$162.50
+0.57 (+0.35%)

Growth Price

$74.83
Overvalued by 53.95%

Company Metrics

  • P/E 41.24
  • P/S 4.35
  • P/B 3.01
  • EPS 3.94
  • Cash ROIC 7.18%
  • Cash Ratio 0.03
  • Dividend 0.06 / 0.04 %
  • Avg. Vol. 391,476.00
  • Shares 48.37M
  • Market Cap. 7.86B

Company Description

The Cooper Companies, Inc., through its subsidiaries, develops, manufactures, and markets healthcare products serving the vision care and women's healthcare markets worldwide. It offers a range of soft contact lenses for the vision care market, such as toric lenses, which correct astigmatism; multifocal lenses for presbyopia; and spherical lenses that correct the common visual defects. The company... more


Download 10 Years of Financial Statements:
Income Statement   Balance Sheet   Cash Flow

News

The Cooper Companies Acquires Assets of Recombine
GlobeNewswire (press release) - May 25, 2016
PLEASANTON, Calif., May 25, 2016 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE:COO) today announced that CooperSurgical has acquired the commercial assets of Recombine Inc., a clinical genetic testing company specializing in carrier ...
Cooper Companies Inc (NYSE:COO) Yearly EPS Forecast At $2.17 - Investor Newswire
Cooper Companies Inc (NYSE:COO) Quarterly EPS From Continuing Operations ... - Enterprise Leader
Cooper Companies Arm Acquires Recombine Assets for $85M
Zacks.com - May 27, 2016
A division of The Cooper Companies Inc. (COO - Analyst Report) , CooperSurgical (CSI), recently acquired the commercial assets of New York-based Recombine Inc., for approximately $85 million.
Cleveland Research Upgrades Cooper Companies Inc to Buy
Trade Calls - May 22, 2016
Brokerage firm Cleveland Research Upgrades its rating on Cooper Companies Inc(NYSE:COO). The shares have been rated Buy. Previously, the analysts had a Neutral rating on the shares.
Upgrades And Downgrades For Cooper Companies, Inc. (The) (NYSE:COO)
Risers & Fallers - May 27, 2016
Recently stock market analysts have updated their consensus ratings on shares of Cooper Companies, Inc. (The) (NYSE:COO).
Stock Upgrades: The Cooper Companies Inc. (COO)
CWRU Observer - Apr 18, 2016
The Cooper Companies Inc. (COO) received a stock rating upgrade from Jefferies on April 15, 2016. In a note to investors, the firm issued a Buy rating.
The Cooper Companies' Women's Health Care Unit Acquires Research Instruments
GlobeNewswire (press release) - Dec 17, 2015
PLEASANTON, Calif., Dec. 17, 2015 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE:COO) today announced that CooperSurgical, its women's health care unit, has acquired Research Instruments Limited, a specialist manufacturer and supplier ...
Cooper Companies Inc (NYSE:COO) Tracking Stock Rating and Target Projections
The Post - May 27, 2016
Out of the 9 covering Wall Street analysts providing share ratings for Cooper Companies Inc (NYSE:COO), 7 have rated the stock as a Strong Buy while 1 analysts have the stock listed as a Buy.
Hold Calls Count For Cooper Companies Inc (NYSE:COO) At 3 - Equities Focus
Cooper Companies Inc (NYSE:COO) Target Price Examined
The Post - May 26, 2016
Equity research firms covering Cooper Companies Inc (NYSE:COO) shares have an average target price of $168.555 on the name.
The Cooper Companies Inc. (COO) Analyst Opinion
Zergwatch - Apr 23, 2016
The Cooper Companies Inc. (COO) is now trading near $157.86 and lots of rating firms seem to have a target price set on the stock.
Trader's Recap: Aldeyra Therapeutics, (NASDAQ:ALDX), The Cooper Companies Inc ...
Benchmark Monitor - May 27, 2016
Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) announced the pricing of an underwritten public offering of 2,400,000 shares of its common stock at a price to the public of $5.00 per share.